Successful Treatment of Factor X Deficiency in a Patient with Lymphoplasmacytic Lymphoma with Bendamustine Plus Rituximab Regimen: A Case Report and Literature Review

References

• Bajaj SP, Mann KG. Simultaneous purification of bovine prothrombin and factor X. Activation of prothrombin by trypsin-activated factor X. J Biol Chem. 1973;248(22):7729–7741. doi:10.1016/S0021-9258(19)43250-X
   Web of Science ®Google Scholar
• Sucker C, Zotz RB. The Cell-Based Coagulation Model. In: Marcucci CE, Schoettker P, editors. Perioperative Hemostasis: Coagulation for Anesthesiologists. Berlin, Heidelberg: Springer Berlin Heidelberg; 2015:3–11.
   Google Scholar
• Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood. 2015;125(13):2052–2061. doi:10.1182/blood-2014-08-532820
   PubMed Web of Science ®Google Scholar
• Peyvandi F, Palla R, Menegatti M, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost. 2012;10(4):615–621. doi:10.1111/j.1538-7836.2012.04653.x
   PubMed Web of Science ®Google Scholar
• Menegatti M, Peyvandi F. Treatment of rare factor deficiencies other than hemophilia. Blood. 2019;133(5):415–424. doi:10.1182/blood-2018-06-820738
   PubMed Web of Science ®Google Scholar
• Peyvandi F, Auerswald G, Austin SK. et al. Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency. Blood Rev;2021. 100833. doi:10.1016/j.blre.2021.100833
   Web of Science ®Google Scholar
• Menegatti M, Biguzzi E, Peyvandi F. Management of rare acquired bleeding disorders. Hematology Am Soc Hematol Educ Program. 2019;2019(1):80–87. doi:10.1182/hematology.2019000066
   Google Scholar
• Chan IS, Ogunsile FJ. An Acquired Factor X Inhibitor: the Importance of Understanding Coagulation. Am J Med. 2017;130(7):e307–e8. doi:10.1016/j.amjmed.2017.01.046
   PubMed Web of Science ®Google Scholar
• Hsia CC, Keeney M, Bosco AA, Xenocostas A. Treatment of acquired factor X inhibitor by plasma exchange with concomitant intravenous immunoglobulin and corticosteroids. Am J Hematol. 2008;83(4):318–320. doi:10.1002/ajh.21105
   Web of Science ®Google Scholar
• Lankiewicz MW, Bell WR. A unique circulating inhibitor with specificity for coagulation factor X. Am J Med. 1992;93(3):343–346. doi:10.1016/0002-9343(92)90244-6
   Web of Science ®Google Scholar
• Ness PM, Hymas PG, Gesme D, Perkins HA. An unusual factor-X inhibitor in leprosy. Am J Hematol. 1980;8(4):397–402. doi:10.1002/ajh.2830080408
   Web of Science ®Google Scholar
• Patel G, Hari P, Szabo A, et al. Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced disease. Hematol Oncol Stem Cell Ther. 2019;12(1):10–14. doi:10.1016/j.hemonc.2018.05.002
   PubMedGoogle Scholar
• Furie B, Greene E, Furie BC. Syndrome of acquired factor X deficiency and systemic amyloidosis in vivo studies of the metabolic fate of factor X. N Engl J Med. 1977;297(2):81–85. doi:10.1056/NEJM197707142970203
   Web of Science ®Google Scholar
• Rosenstein ED, Itzkowitz SH, Penziner AS, Cohen JI, Mornaghi RA. Resolution of factor X deficiency in primary amyloidosis following splenectomy. Arch Intern Med. 1983;143(3):597–599. doi:10.1001/archinte.1983.00350030211041
   Google Scholar
• Nixon CP, Prsic EH, Guertin CA, Stevenson RL, Sweeney JD. Acquired Factor XIII inhibitor associated with mantle cell lymphoma. Transfusion. 2017;57(3):694–699. doi:10.1111/trf.13947
   Web of Science ®Google Scholar
• Gesierich W, Munker R, Geiersberger U, Pohlmann H, Brack N, Hartenstein R. Spontaneous Bleeding in a Patient with Malignant Lymphoma: a Case of Acquired Hemophilia. Onkologie. 2000;23(6):584–588.
   Google Scholar
• Aljohani NI, Matthews JH. Acquired factor V inhibitor in a patient with mantle cell lymphoma presenting with hematuria followed by thrombosis: a case report. Int Med Case Rep J. 2014;7:27–30. doi:10.2147/IMCRJ.S59236
   PubMedGoogle Scholar
• Regina S, Colombat P, Fimbel B, Guerois C, Gruel Y. Acquired inhibitor to factor VIII in a patient with Hodgkin’s disease following treatment with interferon-alpha. Haemophilia. 2001;7(5):526–527. doi:10.1046/j.1365-2516.2001.00555.x
   Web of Science ®Google Scholar
• Kelsey PR, Leyland MJ. Acquired inhibitor to human factor VIII associated with paraproteinaemia and subsequent development of chronic lymphatic leukaemia. Br Med J. 1982;285(6336):174–175. doi:10.1136/bmj.285.6336.174
   Web of Science ®Google Scholar
• Lee ES, Hibsman BK, Liebman HA. Acquired bleeding disorder in a patient with malignant lymphoma: antibody-mediated prothrombin deficiency. Cancer. 2001;91(4):636–641. doi:10.1002/1097-0142(20010215)91:4<636::AID-CNCR1046>3.0.CO;2-V
   Web of Science ®Google Scholar
• Lee G, Duan-Porter W, Metjian AD. Acquired, non-amyloid related factor X deficiency: review of the literature. Haemophilia. 2012;18(5):655–663. doi:10.1111/j.1365-2516.2012.02773.x
   PubMed Web of Science ®Google Scholar
• Tashiro H, Shirasaki R, Watanabe M, Kawasugi K, Takahashi Y, Direct Factor SN. X sequestration by systemic amyloid light-chain amyloidosis. Clin Case Rep. 2018;6(3):513–515. doi:10.1002/ccr3.1398
   PubMed Web of Science ®Google Scholar
• Meenhuis A, van Vliet R, Hudig F, Ypma PF, Schipperus MR, Hollestelle MJ. Successful treatment of a noninhibitory antibody-mediated acquired factor X deficiency in a patient with marginal-zone lymphoma. Clin Case Rep. 2015;3(7):587–593. doi:10.1002/ccr3.294
   Google Scholar
• Broze GJ Jr. An acquired, calcium-dependent, factor X inhibitor. Blood Cells Mol Dis. 2014;52(2–3):116–120. doi:10.1016/j.bcmd.2013.09.001
   Web of Science ®Google Scholar
• Kyriakou DS, Alexandrakis MG, Passam FH, et al. Acquired inhibitors to coagulation factors in patients with gastrointestinal diseases. Eur J Gastroenterol Hepatol. 2002;14(12):1383–1387. doi:10.1097/00042737-200212000-00016
   Web of Science ®Google Scholar
• Merlini G, Dispenzieri A, Sanchorawala V, et al. Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers. 2018;4(1):38. doi:10.1038/s41572-018-0034-3
   PubMed Web of Science ®Google Scholar
• Parrondo RD, Reljic T, Iqbal M, et al. Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Waldenström Macroglobulinemia: a Systematic Review and Meta-analysis. Clin Lymphoma Myeloma Leuk. 2020;20(10):e694–e711. doi:10.1016/j.clml.2020.05.021
   Web of Science ®Google Scholar